Implementation of ultra-hypofractionated radiotherapy for breast cancer in the Netherlands in 2020–2023, using registry data and questionnaires by Anouk H. Eijkelboom, Eva J. A. van Beek, Marcel R. Stam, Paulien Westhoff, Marissa C. van Maaren, Margriet G. A. Sattler, Enja J. Bantema-Joppe, Marcel Verheij, Desirée H. J. G. van den Bongard, Sabine Siesling, on behalf of the NABON-COVID-19 Consortium and the COVID and Cancer-NL Consortium

Get full text